Prevalence of irritable bowel syndrome in Southeast Hungary: Impact of Rome III and Rome IV criteria

doi:10.3748/wjg.117254

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 25

This Article

(9)

(12)

(0)

(4)

(167)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jul 7, 2026; 32(25): 117254
Published online Jul 7, 2026. doi: 10.3748/wjg.117254

Table 1 Exclusion criteria of voluntary blood donors

Exclusion criteria of voluntary blood donation
Any virus carrier status, any ongoing acute infection, any malignant disease, blood coagulation and other hematological disorders, epilepsy, Parkinson’s disease, rheumatic heart disease, systemic autoimmune diseases, Graves’ disease, chronic kidney disease, pancreatic disease, liver enlargement, heart surgery, any transplantation
Hypertension	Started or modified therapy within 1 month; severe, inadequate hypertension.
Blood pressure	< 100 mmHg or > 180 mmHg systolic or > 100 mmHg diastolic
Hypothyreosis	Within 180 days from recovery of infection, medicine-induced or traumatic thyroid disease
Hashimoto thyreoiditis	Symptomatic, therapy shorter than 3 months, taking corticosteroids
Bronchial asthma	Symptomatic or uncontrolled
Type 2 diabetes mellitus	Insulin use
Disc herniation	Sciatica within 30 days
Osteoporosis	Severe osteoporosis
Tachycardia/arrhythmia	< 50 bpm or >100 bpm, irregular rhythm for 7 days, presence of murmur
Celiac disease	Symptomatic

Full Size Table

Table 2 General statistical data of the categorical variables, mean ± SD/n (%)

Demographic data	Control (n = 1145)	Irritable bowel syndrome (n = 94)	P value
Age (years)	39.14 ± 12.41	37.83 ± 11.78	0.3236
Body mass index	27.12 ± 4.85	27.62 ± 5.07	0.3385
Quality of life	80.95 ± 14.39	75.37 ± 17.99	0.0004
Household population
Alone	125 (10.9)	7 (7.4)	0.5559
Adults only	442 (38.6)	39 (41.5)
Adults and children	578 (50.5)	48 (51.1)
Residence
Urban	750 (65.5)	68 (72.3)	0.1784
Rural	395 (34.5)	26 (27.7)
Childhood residence
Urban	672 (58.7)	62 (66.0)	0.1681
Rural	473 (41.3)	32 (34.0)
Occupation
Student	153 (13.3)	14 (14.9)	0.0006
Intellectual	509 (44.5)	59 (62.8)
Physical	483 (42.2)	21 (22.3)
Smoking
Smoker	282 (24.6)	22 (23.4)	0.8976
Non-smoker	699 (61.1)	57 (60.6)
Former smoker	164 (14.3)	15 (16.0)
Coffee consumption
More than 1	519 (45.3)	46 (48.9)	0.7816
1/day	270 (23.6)	20 (21.3)
Never	356 (31.1)	28 (29.8)
Alcohol consumption
Regular	45 (3.9)	3 (3.2)	0.3438
Occasional	848 (74.1)	76 (80.8)
Never	252 (22.0)	15 (16.0)

Full Size Table

Table 3 Comparison of prevalence of chronic illnesses in blood donors with and without irritable bowel syndrome based on Rome III and IV criteria, n (%)

Item		Blood donors (n = 1239)		P value
Item		With chronic illness	Without chronic illness	P value
Rome III	Patients with IBS	25 (9.6)	69 (7.1)	0.1714
Rome III	Patients without IBS	236 (90.4)	909 (92.9)	0.1714
Rome IV	Patients with IBS	3 (1.1)	6 (0.6)	0.4080
Rome IV	Patients without IBS	258 (98.9)	972 (99.4)	0.4080

IBS: Irritable bowel syndrome.

Full Size Table

Table 4 Comparison of prevalence of chronic illnesses in patients with psychiatric diseases with irritable bowel syndrome based on Rome III and IV criteria, n (%)

Item		Patients with psychiatric diseases (n = 695)		P value
Item		With chronic illness	Without chronic illness	P value
Rome III	Patients with IBS	82 (16.8)	25 (12.1)	0.1144
Rome III	Patients without IBS	406 (83.2)	182 (87.9)	0.1144
Rome IV	Patients with IBS	29 (5.9)	6 (2.9)	0.0933
Rome IV	Patients without IBS	459 (94.1)	201 (97.1)	0.0933

IBS: Irritable bowel syndrome.

Full Size Table

Table 5 Prevalence of different psychiatric diseases in patients with irritable bowel syndrome based on Rome III and IV criteria, n (%)

P = 0.96	IBS (Rome III)	IBS (Rome IV)
Depression	20 (18.7)	6 (17.1)
Anxiety	10 (9.3)	3 (8.6)
Both	67 (62.7)	24 (68.6)
Neither	10 (9.3)	2 (5.7)

IBS: Irritable bowel syndrome.

Full Size Table

Table 6 Irritable bowel syndrome prevalence in blood donors and psychiatric patients, n (%)/mean (minimum-maximum)/mean ± SD (minimum-maximum)

Item	Blood donors (n = 1239)	Psychiatric patients (n = 695)	Patients with psychiatric diseases (n = 695)
Item	Blood donors (n = 1239)	Psychiatric patients (n = 695)	Depression (n = 136)	Anxiety (n = 69)	Both (n = 408)	Neither (n = 82)
IBS Rome III	94 (7.6)	107 (15.4)	20 (14.7)	10 (14.5)	67 (16.4)	10 (12.2)
IBS Rome IV	9 (0.7)	35 (5.0)	7 (5.1)	3 (4.4)	24 (5.9)	1 (1.2)
Males	699 (56.4)	159 (22.9)	26 (19.1)	17 (24.6)	91 (22.3)	25 (30.5)
Females	540 (43.6)	536 (77.1)	110 (80.9)	52 (75.4)	317 (77.7)	57 (69.5)
Age	39 (17-66)	62.3 ± 13.1 (24-95)	62.0 ± 12.4 (24-90)	57.9 ± 14.8 (24-81)	63.9 ± 12.4 (26-95)	58.1 ± 14.8 (30-82)

IBS: Irritable bowel syndrome.

Full Size Table

Citation: Ollé G, Helle K, Inczefi O, Róka R, Kovács M, Youssef M, Rosztóczy A. Prevalence of irritable bowel syndrome in Southeast Hungary: Impact of Rome III and Rome IV criteria. World J Gastroenterol 2026; 32(25): 117254
URL: https://www.wjgnet.com/1007-9327/full/v32/i25/117254.htm
DOI: https://dx.doi.org/10.3748/wjg.117254

Ollé G, Helle K, Inczefi O, Róka R, Kovács M, Youssef M, Rosztóczy A. Prevalence of irritable bowel syndrome in Southeast Hungary: Impact of Rome III and Rome IV criteria. World J Gastroenterol 2026; 32(25): 117254 [DOI: 10.3748/wjg.117254]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.